Company intelligence / Profile preview
LIPIN Pharmaceutical
- Ownership
- Private
- Employees
- ~350
- Development stage
- Other
Overview
Lipin Pharmaceutical is a biopharmaceutical company focused on the development of innovative drug delivery systems and complex formulations. The company utilizes its proprietary platforms, including Lipin-Film and Lipin-Sustained, to develop improved versions of existing medications via the 505(b)(2) regulatory pathway. Its product pipeline primarily targets therapeutic areas such as neurology, cardiovascular diseases, and pain management. Lipin aims to improve patient compliance and therapeutic outcomes through advanced oral thin films and sustained-release technologies. The company maintains research and manufacturing facilities in China and targets both domestic and international markets.
- Therapeutic areas
- GastroenterologyCardiovascularPsychiatryNeurology
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on LIPIN Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LIPIN Pharmaceutical.